Clinical Trial Update: Additional 4 Cycles of Cisplatin (CDDP4) in Patients With Triple Negative Breast Cancer for Neoadjuvant Chemotherapy [Phase 2]

View source ↗

Summary

A Phase 2 trial update exploring the addition of four cycles of cisplatin (CDDP4) as neoadjuvant chemotherapy for patients with triple-negative breast cancer; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• CISPLATIN (cisplatin)

Snippet

Sponsor: Asan Medical Center | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED